nfr-logonfr-logo
PROSJEKTBANKEN
Switch to English
Se statistikken
Se prosjektene

0 antall prosjekter

Dato fra ny til gammel

H20-HEALTH-Health, demographic change and wellbeing

Innovations to accelerate vaccine development and manufacture

Innovations to accelerate vaccine development and manufacture

Tildelt: kr 16,5 mill.

Prosjektperiode: 2021-2027

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

Tildelt: kr 10,6 mill.

Prosjektperiode: 2021-2026

Sted: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Tildelt: kr 3,4 mill.

Prosjektperiode: 2021-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life. It is our vision that engagement o...

Tildelt: kr 32,1 mill.

Prosjektperiode: 2020-2025

Sted: Oslo og 3 andre

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Tildelt: kr 0,63 mill.

Prosjektperiode: 2020-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Tildelt: kr 1,2 mill.

Prosjektperiode: 2019-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Tildelt: kr 2,3 mill.

Prosjektperiode: 2019-2025

Sted: Rogaland

H20-HEALTH-Health, demographic change and wellbeing

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions, SMEs, and 8 major pharmaceutical companies, teamed to study a fundamental issue in medicine: the mechanisms of response and non-response to therapies, the ...

Tildelt: kr 2,0 mill.

Prosjektperiode: 2019-2026

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre)clinical research that Nic...

Tildelt: kr 0,30 mill.

Prosjektperiode: 2019-2022

Sted: Rogaland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Tildelt: kr 20,2 mill.

Prosjektperiode: 2019-2024

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation. What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety...

Tildelt: kr 7,0 mill.

Prosjektperiode: 2019-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

Tildelt: kr 1,0 mill.

Prosjektperiode: 2019-2024

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Vaccines and Infectious Diseases in the Ageing PopuLation

Vaccines and Infectious Diseases in the Ageing PopuLation

Tildelt: kr 3,3 mill.

Prosjektperiode: 2019-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Bringing a prophylactic Ebola vaccine to licensure

Bringing a prophylactic Ebola vaccine to licensure

Tildelt: Skjult

Prosjektperiode: 2018-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Tildelt: kr 6,5 mill.

Prosjektperiode: 2018-2024

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findings from in vitro and animal models into effective clinical interventions. INNODIA aims to achieve a breakthrough in the way in which we study T1D to enable ...

Tildelt: kr 3,5 mill.

Prosjektperiode: 2015-2022

Sted: Oslo

1